Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on May 27th, 2025 | 07:20 CEST
Tariff chaos as a springboard: How Volkswagen, European Lithium, and BYD are securing future profits
The global automotive industry is in a quandary: New US punitive tariffs of up to 50% on imported vehicles threaten to sideline European manufacturers. Even though Donald Trump is giving Europe more time for negotiations, the tariffs are still on the table. These tariffs would result in a slump in exports and shrinking margins. But there is also an opportunity amid the chaos. Those who strengthen local supply chains, drive forward electric innovations, and cooperate strategically will dominate tomorrow's market. Therefore, we look at two major automakers, Volkswagen and BYD, and analyze European Lithium, which will become very important for European supply chains.
Read
Commented by Armin Schulz on May 22nd, 2025 | 07:10 CEST
Overlooked gems? Why artificial intelligence will catapult Novo Nordisk, NetraMark, and UnitedHealth to the forefront
The pharmaceutical industry is undergoing a historic transformation. Artificial intelligence is compressing drug development times from decades to months, reducing costs by billions, and unlocking therapies for previously untreatable diseases. Algorithms sift through genome data, simulate drug candidates, and optimize clinical trials with a precision that surpasses that of human researchers. This disruption is not only creating medical milestones but also lucrative opportunities for investors. Today, we look at three candidates and analyze the current situation at Novo Nordisk, NetraMark Holdings, and UnitedHealth.
Read
Commented by Armin Schulz on May 21st, 2025 | 07:05 CEST
Disruptive thinking, maximum profit: Why Super Micro Computer, MiMedia Holdings, and Xiaomi will boom in 2025
2025 is the year of disruptive pioneers: While AI is not only optimizing processes but also radically transforming industries, companies are focusing on business models that break old rules. It is not adaptation that counts here, but destruction, of monopolized markets, outdated supply chains, and rigid customer expectations. Three players stand out: a server innovator revolutionizing data centers; a cloud pioneer redefining the user experience; and a tech giant linking consumer goods with AI ecosystems. Their strategies? Scalability, platform power, and cross-industry solutions. Super Micro Computer, MiMedia Holdings, and Xiaomi show that disruption not only creates value, but it also dictates the rules of the game.
Read
Commented by Armin Schulz on May 20th, 2025 | 07:00 CEST
Hydrogen from niche market to cash cow: BYD, First Hydrogen, and Plug Power – Who is performing best?
The mobility transition is looking for solutions beyond batteries - and is finding them in a technology that refuels faster and drives further than any electric vehicle. While electromobility shines in urban areas, hydrogen is revolutionizing logistics, long-haul transport, and the heavy-duty sector with its seamless practicality. Regulatory initiatives and billion-dollar infrastructure projects are fueling the market. But who will benefit first? Key players are not relying on visions of the future, but on hard facts such as scalable technology, government support, and an industry hungry for decarbonization. While BYD and First Hydrogen are progressing, Plug Power is struggling with financial issues on its path to profitability.
Read
Commented by Armin Schulz on May 19th, 2025 | 07:00 CEST
Palantir, Credissential, D-Wave Quantum – How to harness the USD 1.4 trillion tsunami
The global tech landscape is on the verge of a historic transformation. An unprecedented capital influx of USD 1.4 trillion from the United Arab Emirates is flooding key industries of the future – AI, digital infrastructure, and quantum computing in the US. As nations battle for supremacy, hyperscale markets are emerging that are revolutionizing startups and corporations alike. Industries from energy to fintech are benefiting from unprecedented investments in computing power, digitalization, and data ecosystems. But who stands to gain? The answer lies in companies that strategically combine algorithms, security, digital business processes, and quantum leaps - and are rewriting the rules of value creation. Three names stand out: Palantir, Credissential, and D-Wave Quantum.
Read
Commented by Armin Schulz on May 15th, 2025 | 07:10 CEST
Exploding profits? BYD's exports, Power Metallic Mines' drilling, Mercedes-Benz's tariff tactics
The mobility transition is accelerating, but the road to an electric future is fraught with dynamics and dilemmas. While global demand for electric vehicles is exploding, shortages of key raw materials such as nickel, copper, lithium, and cobalt threaten to slow down ambitions. Innovations in recycling, alternative materials, and ethical sourcing are becoming a decisive competitive advantage. At the same time, new technologies and government subsidies are pushing the market into an era full of opportunities. Three players are at the center of this upheaval: BYD as a battery pioneer, Power Metallic Mines as a raw material supplier, and Mercedes-Benz as a premium manufacturer, who are jointly rewriting the rules of the green revolution.
Read
Commented by Armin Schulz on May 14th, 2025 | 07:00 CEST
Patents, partnerships & tumor strategies: How Novo Nordisk, BioNxt Solutions, and BioNTech are securing tomorrow's profits
The global pharmaceutical industry, once the epitome of stable investments, is undergoing radical change. While protectionist trade barriers are disrupting supply chains and causing stock market prices to plummet, companies are forecasting growth for the biotech and pharmaceutical industries, according to the industry study "Life Sciences Executives Flash Report." The crisis is turning out to be a laboratory of opportunities – those who prioritize digital therapies, mRNA technologies, or sustainable production models now could emerge as winners in a reorganized market. But which strategies are convincing? We take a closer look at Novo Nordisk, BioNxt Solutions, and BioNTech.
Read
Commented by Armin Schulz on May 13th, 2025 | 07:00 CEST
When returns meet security: Why Almonty Industries is suddenly everyone's darling!
In 2025, the world looks at a map full of conflicts: tensions are escalating in Ukraine, the Middle East, and along new geopolitical fault lines in Asia and Africa. Hopes for peace are giving way to a reality of rearmament and militarization. This dynamic is fueling the defense industry. But its boom depends on an inconspicuous metal: tungsten. With its unique heat resistance and density, it is irreplaceable for armor-piercing ammunition, missiles, and high-performance alloys. While China dominates the global market, a Canadian company is stepping into the spotlight: Almonty Industries. With the revival of the legendary Sangdong mine in South Korea and strategic partnerships, Almonty could become a key player for the West.
Read
Commented by Armin Schulz on May 12th, 2025 | 07:00 CEST
From the valley of tears to hypergrowth? Nel ASA, dynaCERT, and Plug Power in the crosshairs
Does the future of the energy sector lie in hydrogen? After a decade of hype and disillusionment, 2025 is shaping up to be a turning point. Hydrogen is set to flow through Germany's new core grid for the first time, while global megaprojects drive the decarbonization of everything from steelworks to aircraft. The market could grow by 12% annually until 2030, fueled by billions in government funding, industry alliances, and innovative storage solutions. But can hydrogen make the leap from the lab to mass application? In this key phase, three players are stepping into the spotlight: Nel ASA, dynaCERT, and Plug Power.
Read
Commented by Armin Schulz on May 8th, 2025 | 07:05 CEST
Cancer revolution: How Bayer, Vidac Pharma, and Pfizer are shaking up the billion-dollar market
Oncology has become the scene of an unprecedented competition. Where billion-dollar markets meet life-saving innovations, a global playing field for pioneers is emerging. Forecasts show that therapy costs and market volume are growing exponentially. This poses a challenge for healthcare systems and represents a gold mine for visionaries. New technologies such as personalized cancer vaccines and targeted drugs are pushing the boundaries of what is possible. Three players are strategically positioning themselves in this dynamic environment: Bayer, Vidac Pharma, and Pfizer. Their next moves could shape not only patients' lives, but entire industries.
Read